
Vijay Remedies Limited
About Vijay Remedies Limited
Data last updated:
Vijay Remedies Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PLC057803. Its GSTIN is 02AAACV4182H1ZK (Himachal Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.3 Cr. It is led by directors including Vijay Kumar (Managing Director) and Harish Kumar Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 104 Palco House 2162/ T – 10 Main Patel Road, Delhi, India – 110008.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.31 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5 Lakh (net margin -27.3%) and EBITDA of -₹4.89 Lakh (EBITDA margin -26.7%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹2.9 Cr and satisfied charges of ₹1.7 Cr on record. Court records list 25 cases involving the company, including 8 filed by the company and 17 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Vijay Remedies has one previous CIN (Corporate Identification Number): L74899DL1994PLC057803. The current CIN is U74899DL1994PLC057803, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899DL1994PLC057803 | Current |
| L74899DL1994PLC057803 | Previous |
Contact details
Vijay Remedies Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address104 Palco House 2162/ T – 10 Main Patel Road, Delhi, India – 110008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vijay Remedies Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vijay Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vijay Remedies Limited, buy the company report.
Financials of Vijay Remedies Limited
FY 2025 filings availableVijay Remedies Limited reported revenue of ₹18.31 Lakh (up 167% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 167% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 22%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -26.7% | ||||
| Net Profit Margin | -27.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vijay Remedies Limited, buy the company report.
Board of directors of Vijay Remedies Limited
Vijay Remedies has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Kumar Aggarwal Also directs: VRL Crop Remedies Private Limited | Additional Director | 24 Feb 2021 | 5 Years 8 Months | Current |
| Vijay Kumar Also directs: Adhunik Fertichem Limited, VRL Crop Remedies Private Limited | Managing Director | 12 Jul 1998 | 28 Years 4 Months | Current |
| Amit Aggarwal | Additional Director | 28 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Vijay Remedies Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nigpa Pharma Private Limited | ₹18.42 Lakh (FY 2016) | 15.0% | Aurangabad, Maharashtra, India | |||
| Vijay Remedies Limitedthis company | ₹18.31 Lakh (FY 2025) | -₹5 Lakh | -27.3% | 167.0% | Delhi, India | |
| Stepan Laboratories Private Limited | ₹18.27 Lakh (FY 2025) | -76.0% | New Delhi, Delhi, India | |||
| Sryntek Pharmaceutical Private Limited | ₹18.19 Lakh (FY 2025) | 28.0% | Pune, Maharashtra, India | |||
| Relivaid Healthcare India Private Limited | ₹18.18 Lakh (FY 2021) | Mumbai, Maharashtra, India |
To see the full peer comparison of Vijay Remedies Limited, buy the company report.
Auditor
Vijay Remedies Limited is audited by KAKKAR NAVNEET & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAKKAR NAVNEET & ASSOCIATES | FY 2016 | 015393N |
Shareholding
The shareholding of Vijay Remedies Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Vijay Remedies Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Apr 2011 | 10284163 | Indian Bank | ₹15 Lakh | Open | |
| 07 Sep 2010 | 10239155 | Indian Bank | ₹25 Lakh | Open | |
| 01 May 2010 | 10220943 | Indian Bank | ₹40 Lakh | Open | |
| 21 Apr 2009 | 10155424 | Indian Bank | ₹25 Lakh | Open | |
| 12 Aug 2008 | 10119436 | Indian Bank | ₹1.85 Cr | Open |
To see the full charge records of Vijay Remedies Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Vijay Remedies Limited has 25 court cases on record: 8 filed by Vijay Remedies, 17 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 21 | 17 | 0 |
| High courts | 4 | 0 | 0 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Execution petition | Filed against the company by Union Roadways Limited | Disposed |
| District court, New Delhi, Delhi | Criminal case | Filed against the company by M/S Delhi Tin Met Ltd | Disposed |
| District court, Chandigarh | Court case (CS CJ) | Filed against the company by Union Roadways Limited 5 | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Crop Chemical India Ltd | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Ms Agrico Organics Ltd | Disposed |
To see the full case history of Vijay Remedies Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vijay Remedies Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vijay Remedies has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAACV4182H1ZK | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vijay Remedies Limited, buy the company report.
Recent activity
Vijay Remedies Limited has 12 board changes on record since 1998: 3 appointments and 9 cessations. The latest: Amit Aggarwal was appointed as Additional Director on 28 Oct 2021.
23 earlier events are in the company report.
Frequently asked questions
Vijay Remedies is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 March 1994 (32+ years old) and is registered under CIN U74899DL1994PLC057803.
Vijay Remedies has 3 current directors:
- Vijay Kumar - Managing Director
- Harish Kumar Aggarwal - Additional Director
- Amit Aggarwal - Additional Director
The latest financial statements of Vijay Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vijay Remedies is 02AAACV4182H1ZK, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Vijay Remedies is U74899DL1994PLC057803. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vijay Remedies has 25 court cases on record: 8 filed by the company and 17 filed against it. Most are in the district courts.
Vijay Remedies was incorporated on 08 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vijay Remedies by revenue are Nigpa Pharma Private Limited, Stepan Laboratories Private Limited, Sryntek Pharmaceutical Private Limited, Relivaid Healthcare India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Aggarwal was appointed as Additional Director on 28 Oct 2021. Ashok Kumar ceased to be Additional Director on 28 Oct 2021. Harish Kumar Aggarwal was appointed as Additional Director on 24 Feb 2021. Vijay Remedies has 12 board changes on record in total.
The registered office of Vijay Remedies is at 104 Palco House 2162 T – 10 Main Patel Road, Delhi, India – 110008.
Vijay Remedies operates in the pharma industry, in the drug formulation and development segment.

